InnaVirVax's Series A Round

InnaVirVax raised a round of funding on February 14, 2012.

InnaVirVax is a biopharmaceutical company researching and developing therapeutic and diagnostic solutions for diseases linked to the immune system. Through its research on immune dysregulations, the c…

Articles about InnaVirVax's Series A Round: